BRIDGET KENNEDY: Open Payments
NPI 1518685395 · NEWTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 21 payments from 13 companies in 2025. Trend: 2023 $408 · 2024 $604 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $82 |
| EMD Serono, Inc. | 3 | $65 |
| UCB, Inc. | 3 | $63 |
| Amgen Inc. | 1 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $26 |
| Impel Pharmaceuticals LLC | 1 | $24 |
| Celgene Corporation | 1 | $23 |
Products named: Zilbrysq, VYALEV, UPLIZNA, KESIMPTA, ULTOMIRIS, HYQVIA, Ocrevus Zunovo, UBRELVY.
Industry payments across PA — which companies pay providers there.
